{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:51Z","timestamp":1707524691956},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,29]]},"DOI":"10.7759\/cureus.30859","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T06:41:56Z","timestamp":1667112116000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Occurrence of Stargardt Disease in a Quadragenarian Adult"],"prefix":"10.7759","author":[{"given":"Saket Y","family":"Maheshwari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swarupa","family":"Chakole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Stargardt macular degeneration. MedlinePlus Genetics. (2022). Accessed: October 19, 2022: https:\/\/medlineplus.gov\/genetics\/condition\/stargardt-macular-degeneration\/.."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)93026-3","article-title":"Long-term follow-up of Stargardt\u2019s disease and fundus flavimaculatus","volume":"105","author":"Armstrong JD","year":"1998","unstructured":"Armstrong JD, Meyer D, Xu S, Elfervig JL. Long-term follow-up of Stargardt\u2019s disease and fundus flavimaculatus. Ophthalmology. 1998, 105:448-57. 10.1016\/S0161-6420(98)93026-3","journal-title":"Ophthalmology"},{"key":"ref3","unstructured":"Stargardt disease, RNIB. (2022). Accessed. October 19, 2022: https:\/\/www.rnib.org.uk\/your-eyes\/eye-conditions-az\/stargardt-disease\/."},{"key":"ref4","unstructured":"Clinical and molecular characteristics of childhood-onset Stargardt disease. (2022). Accessed. October 19, 2022: https:\/\/pubmed.ncbi.nlm.nih.gov\/25312043\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0737855100","article-title":"Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration","volume":"100","author":"Radu RA","year":"2003","unstructured":"Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc Natl Acad Sci U S A. 2003, 100:4742-7. 10.1073\/pnas.0737855100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","unstructured":"Stargardt disease, hereditary ocular diseases. (2022). Accessed. October 19, 2022: https:\/\/disorders.eyes.arizona.edu\/handouts\/stargardt-disease."},{"key":"ref7","unstructured":"ABCA4 - an overview. (2022). Accessed. October 19, 2022: https:\/\/www.sciencedirect.com\/topics\/biochemistry-genetics-and-molecular-biology\/abca4."},{"key":"ref8","unstructured":"Stargardt disease. (2022). Accessed. October 19, 2022: https:\/\/www.nei.nih.gov\/learn-about-eye-health\/eye-conditions-and-diseases\/stargardt-disease."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20980","article-title":"Differential disease progression in atrophic age-related macular degeneration and late-onset Stargardt disease","volume":"58","author":"Lindner M","year":"2017","unstructured":"Lindner M, Lambertus S, Mauschitz MM, et al.. Differential disease progression in atrophic age-related macular degeneration and late-onset Stargardt disease. Invest Ophthalmol Vis Sci. 2017, 58:1001-7. 10.1167\/iovs.16-20980","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref10","unstructured":"Genetic characterization of Stargardt clinical phenotype in South Indian patients using sanger and targeted sequencing. (2022). Accessed. October 19, 2022: https:\/\/pubmed.ncbi.nlm.nih.gov\/31934596\/."},{"key":"ref11","unstructured":"Stargardt macular dystrophy - causes, symptoms and treatments. (2022). Accessed. October 19, 2022: https:\/\/www.fightforsight.org.uk\/about-the-eye\/a-z-eye-conditions\/stargardt-macular-dystrophy\/."},{"key":"ref12","unstructured":"Diagnosis and management of Stargardt disease. (2022). Accessed. October 19, 2022: https:\/\/www.aao.org\/eyenet\/article\/diagnosis-management-of-stargardt-disease."},{"key":"ref13","unstructured":"Seeking therapies for Stargardt macular dystrophy . (2022). Accessed. October 19, 2022: https:\/\/retinatoday.com\/articles\/2019-july-aug\/seeking-therapies-for-stargardt-macular-dystrophy."},{"key":"ref14","unstructured":"Stargardt disease research advances \u2014 Foundation Fighting Blindness. (2022). Accessed. October 19, 2022: https:\/\/www.fightingblindness.org\/research\/stargardt-disease-research-advances-6."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/116539-a-rare-occurrence-of-stargardt-disease-in-a-quadragenarian-adult","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:28Z","timestamp":1707507808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/116539-a-rare-occurrence-of-stargardt-disease-in-a-quadragenarian-adult"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.30859","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,29]]}}}